Publications by authors named "Sezai Tunc"

Claim this Profile
S
Severe fluoropyrimidine toxicity in a patient with rectal adenocarcinoma with c.2846A>T heterozygous mutation: A case report.
Sezai Tunc, Ogur Karhan

Oncol Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.
Ogur Karhan, Serdar İleri, Zuhat Urakçı, Yasin Sezgin, Ümit Yıldırım

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study.
Ogur Karhan, Serdar İleri, Zuhat Urakçı, Hayati Arvas, Delyadıl Karakaş Kılıç

Oncology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.
Yasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, Muslih Ürün, Berrak Mermit Erçek

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.
Gökhan Uçar, Serhat Sekmek, İrfan Karahan, Yakup Ergün, Özlem Aydın İsak

Oncology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience.
Yasin Sezgin, Ogur Karhan, Serdar Ileri, Senar Ebinc, Sezai Tunc

J Coll Physicians Surg Pak· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer.
Zuhat Urakçı, Senar Ebinç, Sezai Tunç, Ziya Kalkan, Zeynep Oruç

Cureus· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
Emre Yekedüz, Mehmet Fatih Özbay, Dilek Çağlayan, Atila Yıldırım, Cihan Erol

Eur J Clin Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis